Tiblio
Sign Up

AHG

Akso Health Group ADR
NASDAQHEALTHCAREMEDICAL DISTRIBUTION

Key Statistics

Market Cap
$1.30B
P/E Ratio
—
EPS
$-0.48
Beta
-1.00
52W High
$2.50
52W Low
$1.10
50-Day MA
$1.61
200-Day MA
$1.66
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—

About Akso Health Group ADR

Akso Health Group ADR is a leading innovator in the healthcare sector, focused on delivering advanced medical solutions and comprehensive patient care services. The company harnesses state-of-the-art health technologies to drive growth in areas such as telehealth and personalized medicine, supported by a strong emphasis on research and development. With a resilient business model and a dedicated team, Akso Health Group presents an attractive investment opportunity for institutional investors, poised to capitalize on the ongoing transformation within the healthcare industry.

Official WebsiteChinaFY End: March

Fundamentals

Revenue (TTM)$14.84M
Gross Profit (TTM)148,580
EBITDA$-1.46M
Operating Margin-20.50%
Return on Equity-68.30%
Return on Assets-1.42%
Revenue/Share (TTM)$0.03
Book Value$0.23
Price-to-Book6.57
Price-to-Sales (TTM)87.74
EV/Revenue86.99
EV/EBITDA-0.39
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)0.90%
Shares Outstanding$854.04M
Float$854.05M
% Insiders0.00%
% Institutions0.03%

Historical Volatility

HV 10-Day
82.18%
HV 20-Day
86.59%
HV 30-Day
76.75%
HV 60-Day
82.47%
HV Rank
39.3%

Volatility is currently expanding

Latest News

AHG Announces Initiation of World-Class, Proprietary Brain-Computer Interface R&D Program - Targeting the Next Frontier of Human Neurotechnology

QINGDAO, China, April 27, 2026 /PRNewswire/ -- Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") today announced the commencement of its next-generation, proprietary Brain-Computer Interface (BCI) technology research and development program. The Company is establishing the foundational R&D infrastructure necessary to develop and commercialize BCI technology, which it believes represents one of the most transformative and high-value technology frontiers of the 21st century.

PRNewsWire4/27/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AHG and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

LLYEli Lilly and CompanyJNJJohnson & JohnsonABBVAbbVie IncUNHUnitedHealth Group IncorporatedMRKMerck & Company IncNVSNovartis AG ADRAZNAstraZeneca PLCNVONovo Nordisk A/SAMGNAmgen IncTMOThermo Fisher Scientific IncABTAbbott LaboratoriesGILDGilead Sciences Inc
View all HEALTHCARE stocks →
Data last updated: 7/13/2026